DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Hohnloser SH, Camm J, Cappato R. et al.
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
Eur Heart J 2019;
40 (36) 3013-3021
We do not assume any responsibility for the contents of the web pages of other providers.